Cardiovascular Medicine

2 pages, 2440 KB

Open AccessEditorial

Der Leiter des Universitären Herzzentrums Zürich, Professor Thomas F. Lüscher, Folgt Einem Ruf Nach London—Und Bleibt Doch Ein Bisschen in Zürich

by Thomas F. Lüscher

Cardiovasc. Med. 2017, 20(9), 219; https://doi.org/10.4414/cvm.2017.00516 - 20 Sep 2017

Viewed by 8

Abstract

Von der Abteilung Kardiologie zum Herzzentrum Professor Thomas F. Lüscher wurde vor 20 Jahren von der Universität und dem Inselspital Bern auf den Lehrstuhl für Kardiologie nach Zürich berufen [...] Full article

3 pages, 375 KB

Open AccessInteresting Images

Incomplete Stent Apposition Resolves One Year After Implantation

by Florian Basile Stierlin, Stéphane Cook and Mathieu Stadelmann

Cardiovasc. Med. 2017, 20(9), 216; https://doi.org/10.4414/cvm.2017.00515 - 20 Sep 2017

Viewed by 8

Abstract

Incomplete stent apposition (ISA) is proven to increase thrombotic risk, particularly late stent thrombosis of a drug-eluting stent. Less is known about ISA and bioresorbable scaffold (BRS). We describe the coronary angiogram and optical coherence tomography (OCT) changes at one year in a [...] Read more.

Incomplete stent apposition (ISA) is proven to increase thrombotic risk, particularly late stent thrombosis of a drug-eluting stent. Less is known about ISA and bioresorbable scaffold (BRS). We describe the coronary angiogram and optical coherence tomography (OCT) changes at one year in a patient with ISA of Magmaris BRS, in the context of coronary artery disease without acute coronary syndrome. In this particular case, the OCT demonstrated a very good result with complete stent resorption, suggesting that the rapid BRS kinetics resorption could lessen the risk of complications attributed to ISA. Full article

3 pages, 856 KB

Open AccessCase Report

Long-Term Survival After Heart Transplantation

by Mattia Cattaneo, Luca Mazzucchelli, Barbara Rüsi-Elsener, Thomas Fehr and Augusto Gallino

Cardiovasc. Med. 2017, 20(9), 210; https://doi.org/10.4414/cvm.2017.00510 - 20 Sep 2017

Viewed by 17

Abstract

Orthotopic heart transplantation (HTX) represents the gold standard treatment for patients with advanced heart failure. The post-transplant survival of adult HTX recipients has consistently improved in past decades. As a result of increasing donor-recipient mismatch, as well as important technical and surgical advances, [...] Read more.

Orthotopic heart transplantation (HTX) represents the gold standard treatment for patients with advanced heart failure. The post-transplant survival of adult HTX recipients has consistently improved in past decades. As a result of increasing donor-recipient mismatch, as well as important technical and surgical advances, the attention of the medical community has shifted to ventricular assist devices (VADs) and to total artificial hearts. Here we present a patient who survived for 29 years after HTX at the age of 34 – a Caucasian male who manifested exceptionally few of the usual major post-HTX complications and was without typical cardiac allograft vasculopathy on autopsy. The scientific and medical community should not hesitate to persist with vigorous efforts to support research in transplantation and promote organ donation among the general population. Full article

1 pages, 105 KB

Open AccessReview

Gruentzig, Senning and a Young Surgeon: 40 Years Ago the First Heart Team

by Marko Turina

Cardiovasc. Med. 2017, 20(9), 209; https://doi.org/10.4414/cvm.2017.00494 - 20 Sep 2017

Cited by 1 | Viewed by 12

Abstract

One of the true epochal successes of modern medicine was the development of percutaneous treatment of coronary artery disease, earlier known as percutaneous transluminal coronary angioplasty (PTCA)[...] Full article

6 pages, 2906 KB

Open AccessReview

Tricuspid Regurgitation: Assessment and New Frontiers

by Shingo Kuwata, Michel Zuber, Alberto Pozzoli, Fabian Nietlispach, Felix C. Tanner, Francesco Maisano and Maurizio Taramasso

Cardiovasc. Med. 2017, 20(9), 203; https://doi.org/10.4414/cvm.2017.00514 - 20 Sep 2017

Viewed by 14

Abstract

Tricuspid regurgitation is the most frequent disease of the tricuspid valve. Of these, functional tricuspid regurgitation is the most frequent, and severe insufficiency is associated with an increasing risk of cardiovascular events and bad prognosis. The pathophysiology and assessment of tricuspid regurgitation is [...] Read more.

Tricuspid regurgitation is the most frequent disease of the tricuspid valve. Of these, functional tricuspid regurgitation is the most frequent, and severe insufficiency is associated with an increasing risk of cardiovascular events and bad prognosis. The pathophysiology and assessment of tricuspid regurgitation is essential for transcatheter treatments, new treatment options. The aim of this short review is to summarise the assessment of tricuspid regurgitation and to show new transcatheter therapeutic options. Current experience with these new therapies is preliminary and further studies are needed to develop the evidence of transcatheter tricuspid valve therapy. Full article

7 pages, 589 KB

Open AccessReview

Update on Arrhythmogenic Cardiomyopathies

by Deniz Akdis, Corinna Brunckhorst, Firat Duru and Ardan M. Saguner

Cardiovasc. Med. 2017, 20(9), 196; https://doi.org/10.4414/cvm.2017.00512 - 20 Sep 2017

Viewed by 14

Abstract

Arrhythmogenic cardiomyopathy is a hereditary disease associated with mutations in genes encoding proteins of the intercalated disk, especially desmosomes, mostly affecting the young and athletes. There are three clinical subtypes: the classical right-dominant form, generally referred to as arrhythmogenic right ventricular cardiomyopathy (ARVC), [...] Read more.

Arrhythmogenic cardiomyopathy is a hereditary disease associated with mutations in genes encoding proteins of the intercalated disk, especially desmosomes, mostly affecting the young and athletes. There are three clinical subtypes: the classical right-dominant form, generally referred to as arrhythmogenic right ventricular cardiomyopathy (ARVC), biventricular forms, and left-dominant subtypes. Typical symptoms include palpitations, arrhythmic (pre)syncope, and sudden cardiac arrest due to ventricular tachycardia/ fibrillation (VT/VF). At later stages, heart failure may occur. Diagnosis of classical ARVC is established with the 2010 Task Force Criteria. The 12-lead ECG is important in the assessment of depolarisation and repolarisation abnormalities such as T-wave inversions in the precordial leads, which are the most common ECG abnormality. Imaging tools such as echocardiography and cardiac magnetic resonance are very important for detecting structural and functional alterations. Family history and the detection of causative mutations have been incorporated in the diagnostic criteria to facilitate diagnosis in family members. Differential diagnoses include idiopathic right ventricular outflow tract VT, cardiac sarcoidosis, congenital heart disease, myocarditis, dilated cardiomyopathy, Brugada syndrome, and right ventricular infarction. Therapeutic strategies include restriction from endurance and competitive sports, beta-blockers, antiarrhythmic and heart failure drugs. The implantable cardioverter-defibrillator (ICD) is the only reliable therapy for prevention of sudden cardiac death, and should be considered in intermediate- to high-risk patients. Endocardial/epicardial catheter ablation can be beneficial in patients with recurrent ICD discharges. Full article

1 pages, 153 KB

Open AccessCommunication

In Memoriam: Professeur Daniel Wagner

by Juerg Schwitter and Pierre-François Leyvraz

Cardiovasc. Med. 2017, 20(9), 195; https://doi.org/10.4414/cvm.2017.00509 - 20 Sep 2017

Viewed by 12

Abstract

Chères et Chers collègues, C’est avec une profonde tristesse que nous vous informons du décès de notre très cher collègue, Monsieur le Professeur Daniel Wagner, Chef du Service de Cardiologie[...] Full article

5 pages, 613 KB

Open AccessCase Report

Paradoxical QRS Complex Narrowing Following Transcatheter Aortic Valve Implantation

by Nils Perrin, Harran Burri, Angela Frei and Stéphane Noble

Cardiovasc. Med. 2017, 20(9), 1; https://doi.org/10.4414/cvm.2017.00513 - 20 Sep 2017

Viewed by 14

Abstract

Peri- or postprocedural conduction disorders following transcatheter aortic valve implantation remain frequent, and identification of electrocardiogram predictors of postinterventional high-degree atrioventricular block is challenging. Here we present a case of paradoxical normalisation of QRS complex duration following transcatheter aortic valve implantation, suggesting a [...] Read more.

Peri- or postprocedural conduction disorders following transcatheter aortic valve implantation remain frequent, and identification of electrocardiogram predictors of postinterventional high-degree atrioventricular block is challenging. Here we present a case of paradoxical normalisation of QRS complex duration following transcatheter aortic valve implantation, suggesting a high risk for subsequent complete atrioventricular block. Full article

Journal Menu

Journal Browser

Cardiovasc. Med., Volume 20, Issue 9 (09 2017) – 8 articles

Further Information

Guidelines

MDPI Initiatives

Follow MDPI